Hedge Fund - Tybourne Capital Management
Taysha Gene Therapies Inc. (TSHA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q3 (2025-09-30) | $12,099,000 | 39.11% | 3,700,000 | $2.83 |
| 2 | 2025 - Q2 (2025-06-30) | $9,459,450 | 27.39% | 4,095,000 | $2.17 |
| 3 | 2025 - Q1 (2025-03-31) | $5,143,000 | 21.83% | 3,700,000 | $1.67 |
| 4 | 2024 - Q4 (2024-12-31) | $6,401,000 | 1.6% | 3,700,000 | $2.07 |
| 5 | 2024 - Q3 (2024-09-30) | $7,437,000 | 2.08% | 3,700,000 | $2.19 |
| 6 | 2024 - Q2 (2024-06-30) | $8,288,000 | 1.68% | 3,700,000 | $2.91 |
| 7 | 2024 - Q1 (2024-03-31) | $10,619,000 | 1.81% | 3,700,000 | $2.08 |
| 8 | 2023 - Q4 (2023-12-31) | $6,549,000 | 0.97% | 3,700,000 | $1.99 |
| 9 | 2023 - Q3 (2023-09-30) | $4,740,000 | 0.66% | 1,500,000 | $1.87 |
| 10 | 2023 - Q2 (2023-06-30) | $991,500 | 0.1% | 1,500,000 | $0.72 |
| 11 | 2023 - Q1 (2023-03-31) | $1,196,400 | 0.12% | 1,500,000 | $1.29 |
| 12 | 2022 - Q4 (2022-12-31) | $3,390,000 | 0.33% | 1,500,000 | $2.02 |
| 13 | 2022 - Q3 (2022-09-30) | $965,000 | 0.09% | 500,000 | $3.63 |
| 14 | 2022 - Q2 (2022-06-30) | $1,860,000 | 0.13% | 500,000 | $3.97 |
| 15 | 2022 - Q1 (2022-03-31) | $3,260,000 | 0.19% | 500,000 | $7.48 |
| 16 | 2021 - Q4 (2021-12-31) | $5,825,000 | 0.17% | 500,000 | $15.08 |
| 17 | 2021 - Q3 (2021-09-30) | $9,310,000 | 0.23% | 500,000 | $19.01 |
| 18 | 2021 - Q2 (2021-06-30) | $10,600,000 | 0.22% | 500,000 | $23.05 |
| 19 | 2021 - Q1 (2021-03-31) | $10,150,000 | 0.22% | 500,000 | $27.08 |
| 20 | 2020 - Q4 (2020-12-31) | $13,270,000 | 0.27% | 500,000 | $21.54 |
| 21 | 2020 - Q3 (2020-09-30) | $11,200,000 | 0.27% | 500,000 | $23.52 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center